Exploring Bacteria-Based Cancer Immunotherapy: Comment on "Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics".
作者信息
Li Chen-Xi, Gong Zhong-Cheng
机构信息
Department of Oral and Maxillofacial Oncology and Surgery, School/Hospital of Stomatology, National Clinical Medical Research Institute, Stomatological Research Institute of Xinjiang Uygur Autonomous Region, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Sonnig Biomedical Studio, Urumqi, 830000, China.
出版信息
Adv Sci (Weinh). 2025 Aug;12(30):e06869. doi: 10.1002/advs.202506869. Epub 2025 Jul 25.
Abstract
摘要
相似文献
1
Exploring Bacteria-Based Cancer Immunotherapy: Comment on "Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics".
Adv Sci (Weinh). 2025 Aug;12(30):e06869. doi: 10.1002/advs.202506869. Epub 2025 Jul 25.
2
Reply to "Exploring Bacteria-Based Cancer Immunotherapy"-Comment on "Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics".
Adv Sci (Weinh). 2025 Aug;12(30):e11325. doi: 10.1002/advs.202511325. Epub 2025 Jul 14.
3
Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics.
Adv Sci (Weinh). 2023 Jul;10(20):e2301679. doi: 10.1002/advs.202301679. Epub 2023 May 7.
4
Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics.
Acta Biomater. 2021 Apr 1;124:72-87. doi: 10.1016/j.actbio.2021.02.006. Epub 2021 Feb 6.
5
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.
Immunotherapy. 2025 Apr;17(6):425-435. doi: 10.1080/1750743X.2025.2501926. Epub 2025 May 12.
6
Intratumoral Immunotherapy-Update 2019.
Oncologist. 2020 Mar;25(3):e423-e438. doi: 10.1634/theoncologist.2019-0438. Epub 2019 Nov 29.
7
Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade.
Clin Cancer Res. 2019 Mar 1;25(5):1612-1623. doi: 10.1158/1078-0432.CCR-18-1932. Epub 2018 Dec 11.
8
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.
J Virol. 2020 Jan 17;94(3). doi: 10.1128/JVI.01677-19.
9
Bacterial oncolytic therapy as a novel approach for cancer treatment in humans.
Cancer Treat Res Commun. 2025;43:100892. doi: 10.1016/j.ctarc.2025.100892. Epub 2025 Mar 14.
10
Harnessing intratumoral microbiota: new horizons in immune microenvironment and immunotherapy.
J Transl Med. 2025 Aug 12;23(1):897. doi: 10.1186/s12967-025-06916-2.
本文引用的文献
1
Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis?
Mol Oncol. 2025 Aug;19(8):2171-2173. doi: 10.1002/1878-0261.70037. Epub 2025 Apr 25.
2
Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization.
Cell. 2025 Apr 3;188(7):1842-1857.e20. doi: 10.1016/j.cell.2025.02.002. Epub 2025 Mar 3.
3
Exploiting bacteria for cancer immunotherapy.
Nat Rev Clin Oncol. 2024 Aug;21(8):569-589. doi: 10.1038/s41571-024-00908-9. Epub 2024 Jun 5.
4
Genomic alterations driving precancerous to cancerous lesions in esophageal cancer development.
Cancer Cell. 2023 Dec 11;41(12):2038-2050.e5. doi: 10.1016/j.ccell.2023.11.003. Epub 2023 Nov 30.
5
Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics.
Adv Sci (Weinh). 2023 Jul;10(20):e2301679. doi: 10.1002/advs.202301679. Epub 2023 May 7.
6
Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy.
Front Immunol. 2023 Jan 10;13:1011943. doi: 10.3389/fimmu.2022.1011943. eCollection 2022.
7
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer.
Nature. 2022 Nov;611(7937):810-817. doi: 10.1038/s41586-022-05435-0. Epub 2022 Nov 16.
8
Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma.
Signal Transduct Target Ther. 2022 Sep 28;7(1):335. doi: 10.1038/s41392-022-01159-9.
9
Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer.
Cell. 2022 Apr 14;185(8):1356-1372.e26. doi: 10.1016/j.cell.2022.02.027. Epub 2022 Apr 7.
10
Gut Microbiota Alteration Influences Colorectal Cancer Metastasis to the Liver by Remodeling the Liver Immune Microenvironment.
Gut Liver. 2022 Jul 15;16(4):575-588. doi: 10.5009/gnl210177. Epub 2022 Mar 23.
Zotero 插件